Source:http://linkedlifedata.com/resource/pubmed/id/15245806
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2004-7-12
|
pubmed:abstractText |
On behalf of the European Association of Urology (EAU) guidelines for diagnosis, therapy and follow-up of upper urinary tract transitional cell carcinoma (UUTT) patients were established. Criteria for recommendations are based of level 2 only, as large randomised clinical trials have not been performed in this type of disease.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0302-2838
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
147-54
|
pubmed:meshHeading |
pubmed-meshheading:15245806-Carcinoma, Transitional Cell,
pubmed-meshheading:15245806-Follow-Up Studies,
pubmed-meshheading:15245806-Humans,
pubmed-meshheading:15245806-Kidney Neoplasms,
pubmed-meshheading:15245806-Prognosis,
pubmed-meshheading:15245806-Risk Factors,
pubmed-meshheading:15245806-Ureteral Neoplasms
|
pubmed:year |
2004
|
pubmed:articleTitle |
EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma.
|
pubmed:affiliation |
Department of Urology, University Hospital Ghent, De Pintelaan 185, 9000 Ghent, Belgium. willem.oosterlink@ugent.be
|
pubmed:publicationType |
Journal Article,
Guideline,
Practice Guideline
|